Singapore markets open in 4 hours 41 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
56,708.80 -3,109.50 (-5.20%) CMC Crypto 200
1,195.78 -143.29 (-10.70%)
BioMarin Pharmaceutical Inc. (0HNC.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:00PM BST
| Previous close | 81.02 |
| Open | 81.07 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 81.03 - 82.62 |
| 52-week range | 76.29 - 99.65 |
| Volume | |
| Avg. volume | 5,967 |
| Market cap | 150.471M |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 3.84 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Last week, you might have seen that BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN ) released its first-quarter result to...
- GuruFocus.com
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
- Insider Monkey
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
© 2024 Yahoo. All rights reserved.